# Impact of Obstructive Sleep Apnea (OSA) Treatment on Blood Pressure Control in Chronic Kidney Disease

Study · id `cardio:ct-nct05846490` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05846490](<https://clinicaltrials.gov/study/NCT05846490>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05846490

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.

## Technical summary

Registry record NCT05846490. Randomized; no masking; primary purpose treatment. Start 2024-01-08 (actual); primary completion 2025-05 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 150 participants (planned count; ClinicalTrials.gov record NCT05846490, source copy `cardio:ctgov-nct05846490-2024-06-11`, retrieved 2026-10-26)
- Started: 2024-01-08 (actual) (ClinicalTrials.gov record NCT05846490, source copy `cardio:ctgov-nct05846490-2024-06-11`, retrieved 2026-10-26)
- Primary completion: 2025-05 (anticipated) (ClinicalTrials.gov record NCT05846490, source copy `cardio:ctgov-nct05846490-2024-06-11`, retrieved 2026-10-26)
- Completion: 2026-05 (anticipated) (ClinicalTrials.gov record NCT05846490, source copy `cardio:ctgov-nct05846490-2024-06-11`, retrieved 2026-10-26)
- Countries: Brazil (ClinicalTrials.gov record NCT05846490, source copy `cardio:ctgov-nct05846490-2024-06-11`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05846490-2024-06-11`, retrieved 2026-10-26)

## The registry's words

- Brief title: Impact of Obstructive Sleep Apnea (OSA) Treatment on Blood Pressure Control in Chronic Kidney Disease
- Condition: Sleep Apnea
- Condition: Chronic Kidney Diseases
- Intervention (Device): CPAP
- Intervention (Drug): Usual care
- Lead sponsor: University of Sao Paulo
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: University of Sao Paulo (`cardio:org-university-of-sao-paulo`)

## Provenance

Content hash: e1f946d7bd8cdd91ceee01be889b1f9fe357c759c3e35d3be8c3008d9dd2fb66
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
